Annual Shareholders Equity
$9.66 M
+$2.99 M+44.90%
31 December 2023
Summary:
BioNexus Gene Lab annual stockholders equity is currently $9.66 million, with the most recent change of +$2.99 million (+44.90%) on 31 December 2023. During the last 3 years, it has risen by +$3.00 million (+44.97%). BGLC annual shareholders equity is now at all-time high.BGLC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$9.39 M
-$157.60 K-1.65%
30 September 2024
Summary:
BioNexus Gene Lab quarterly stockholders equity is currently $9.39 million, with the most recent change of -$157.60 thousand (-1.65%) on 30 September 2024. Over the past year, it has dropped by -$299.50 thousand (-3.09%). BGLC quarterly shareholders equity is now -3.09% below its all-time high of $9.69 million, reached on 30 September 2023.BGLC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.9% | -3.1% |
| 3 y3 years | +45.0% | +33.1% |
| 5 y5 years | +534.6% | - |
BGLC Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.0% | -3.1% | +57.4% |
| 5 y | 5 years | at high | +760.5% | -3.1% | +907.8% |
| alltime | all time | at high | +760.5% | -3.1% | +907.8% |
BioNexus Gene Lab Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.39 M(-1.7%) |
| June 2024 | - | $9.55 M(+2.2%) |
| Mar 2024 | - | $9.34 M(-3.2%) |
| Dec 2023 | $9.66 M(+44.9%) | $9.66 M(-0.3%) |
| Sept 2023 | - | $9.69 M(+62.4%) |
| June 2023 | - | $5.96 M(-9.0%) |
| Mar 2023 | - | $6.56 M(-1.6%) |
| Dec 2022 | $6.67 M(-7.2%) | $6.67 M(+3.8%) |
| Sept 2022 | - | $6.42 M(-5.8%) |
| June 2022 | - | $6.82 M(-4.3%) |
| Mar 2022 | - | $7.13 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $7.18 M(+7.8%) | - |
| Dec 2021 | - | $7.18 M(+1.8%) |
| Sept 2021 | - | $7.05 M(+3.5%) |
| June 2021 | - | $6.81 M(+0.3%) |
| Mar 2021 | - | $6.79 M(+2.0%) |
| Dec 2020 | $6.66 M(+493.6%) | $6.66 M(+615.1%) |
| Sept 2020 | - | $931.60 K(-3.9%) |
| June 2020 | - | $969.70 K(-6.1%) |
| Mar 2020 | - | $1.03 M(-8.0%) |
| Dec 2019 | $1.12 M(-26.3%) | $1.12 M |
| Dec 2018 | $1.52 M | - |
FAQ
- What is BioNexus Gene Lab annual stockholders equity?
- What is the all time high annual shareholders equity for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual shareholders equity year-on-year change?
- What is BioNexus Gene Lab quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly shareholders equity year-on-year change?
What is BioNexus Gene Lab annual stockholders equity?
The current annual shareholders equity of BGLC is $9.66 M
What is the all time high annual shareholders equity for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual stockholders equity is $9.66 M
What is BioNexus Gene Lab annual shareholders equity year-on-year change?
Over the past year, BGLC annual stockholders equity has changed by +$2.99 M (+44.90%)
What is BioNexus Gene Lab quarterly stockholders equity?
The current quarterly shareholders equity of BGLC is $9.39 M
What is the all time high quarterly shareholders equity for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly stockholders equity is $9.69 M
What is BioNexus Gene Lab quarterly shareholders equity year-on-year change?
Over the past year, BGLC quarterly stockholders equity has changed by -$299.50 K (-3.09%)